NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Use of “cure” overwhelms any caveats coming later in WaPost Ebola story

Zoloft as Ebola cure? – blared the Washington Post headline.

Zoloft as Ebola cure?

 

“What if the cure for Ebola were already in your local pharmacy?” asked the question-mark journalism first line of the story.

Mouse 410x273This was about a mouse study.

And when you add, deep in the story, “A lot of drugs that look miraculous in mice end up doing nothing in humans,” it is too little too late.

Appreciation of that fact should have entered into the deliberation over what the headline should be, and what the first line of the story should be.

This is about Ebola, not toenail fungus. We should proceed slowly before tossing around the “cure” word in this context.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.